<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://copywritersalute.com/2026/11/12/chirurgia-bariatrica-e-agonisti-glp-1/</loc><news:news><news:publication><news:name>Comunicare Salute</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-11-12T19:17:23+00:00</news:publication_date><news:title>Chirurgia bariatrica e agonisti GLP-1</news:title><news:keywords>diabete, diabete tipo 2, obesità, Osas, sindrome delle apnee ostruttive del sonno, artrosi, apnee notturne, rischio cardiovascolare, diabete 2, GLP-1 agonisti, BMI, scompenso cardiaco, gastrectomia verticale, sleeve gastrectomy, bypass gastrico, bypass gastrico Roux-en-Y, diversione biliopancreatica con duodenal switch, indice di massa corporea, agonisti di GLP-1, steatopatia, semaglutide, tirzepatide</news:keywords></news:news><image:image><image:loc>https://copywritersalute.com/wp-content/uploads/2026/11/chirurgia-bariatrica-obesita-glp-1-sleeve-gastrectomy.png?w=150</image:loc></image:image></url></urlset>
